25 XP   0   0   10

Luyan Pharma Co Ltd
Buy, Hold or Sell?

Let's analyse Luyan together

PenkeI guess you are interested in Luyan Pharma Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Luyan Pharma Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Luyan Pharma Co Ltd

I send you an email if I find something interesting about Luyan Pharma Co Ltd.

Quick analysis of Luyan (30 sec.)










What can you expect buying and holding a share of Luyan? (30 sec.)

How much money do you get?

How much money do you get?
¥0.47
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.18
Expected worth in 1 year
¥9.56
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥5.78
Return On Investment
69.8%

For what price can you sell your share?

Current Price per Share
¥8.28
Expected price per share
¥7.45 - ¥8.4976801346801
How sure are you?
50%

1. Valuation of Luyan (5 min.)




Live pricePrice per Share (EOD)

¥8.28

Intrinsic Value Per Share

¥2.08 - ¥22.30

Total Value Per Share

¥9.27 - ¥29.48

2. Growth of Luyan (5 min.)




Is Luyan growing?

Current yearPrevious yearGrowGrow %
How rich?$385.6m$353.8m$31.8m8.3%

How much money is Luyan making?

Current yearPrevious yearGrowGrow %
Making money$47.7m$42.2m$5.4m11.4%
Net Profit Margin1.8%1.7%--

How much money comes from the company's main activities?

3. Financial Health of Luyan (5 min.)




4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  


Richest
#12 / 46

Most Profit
#12 / 46

What can you expect buying and holding a share of Luyan? (5 min.)

Welcome investor! Luyan's management wants to use your money to grow the business. In return you get a share of Luyan.

What can you expect buying and holding a share of Luyan?

First you should know what it really means to hold a share of Luyan. And how you can make/lose money.

Speculation

The Price per Share of Luyan is ¥8.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Luyan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Luyan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.18. Based on the TTM, the Book Value Change Per Share is ¥0.59 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.85 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Luyan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.121.5%0.121.5%0.111.3%0.101.2%0.060.7%
Usd Book Value Change Per Share0.081.0%0.081.0%0.050.7%0.091.1%0.081.0%
Usd Dividend Per Share0.121.4%0.121.4%0.091.1%0.081.0%0.060.7%
Usd Total Gains Per Share0.202.4%0.202.4%0.141.7%0.172.0%0.141.7%
Usd Price Per Share1.15-1.15-1.08-1.20-1.74-
Price to Earnings Ratio9.38-9.38-9.92-13.54-33.47-
Price-to-Total Gains Ratio5.76-5.76-7.51-8.87-15.89-
Price to Book Ratio1.16-1.16-1.19-1.59-3.03-
Price-to-Total Gains Ratio5.76-5.76-7.51-8.87-15.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.144296
Number of shares873
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.08
Usd Book Value Change Per Share0.080.09
Usd Total Gains Per Share0.200.17
Gains per Quarter (873 shares)174.40145.70
Gains per Year (873 shares)697.58582.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1411286688279304573
282257313865576081156
3123485920848369121739
4164511452782111512172322
5205614323480139315212905
6246717184178167218253488
7287920044876195121294071
8329022915574222924334654
9370125776272250827375237
10411228636970278730415820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%8.00.04.066.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%

Fundamentals of Luyan

About Luyan Pharma Co Ltd

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. The company was founded in 1992 and is headquartered in Xiamen, China.

Fundamental data was last updated by Penke on 2024-04-14 19:39:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Luyan Pharma Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Luyan earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 1.8% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Luyan Pharma Co Ltd:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 1.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY1.7%+0.0%
TTM1.8%5Y1.7%+0.1%
5Y1.7%10Y1.3%+0.4%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%0.4%+1.4%
TTM1.8%0.4%+1.4%
YOY1.7%0.3%+1.4%
5Y1.7%1.1%+0.6%
10Y1.3%1.4%-0.1%
1.1.2. Return on Assets

Shows how efficient Luyan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • 2.9% Return on Assets means that Luyan generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Luyan Pharma Co Ltd:

  • The MRQ is 2.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.9%0.0%
TTM2.9%YOY3.1%-0.1%
TTM2.9%5Y3.1%-0.2%
5Y3.1%10Y2.5%+0.6%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%0.2%+2.7%
TTM2.9%0.3%+2.6%
YOY3.1%0.2%+2.9%
5Y3.1%0.3%+2.8%
10Y2.5%0.2%+2.3%
1.1.3. Return on Equity

Shows how efficient Luyan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • 12.7% Return on Equity means Luyan generated ¥0.13 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Luyan Pharma Co Ltd:

  • The MRQ is 12.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.7%TTM12.7%0.0%
TTM12.7%YOY12.3%+0.4%
TTM12.7%5Y12.4%+0.3%
5Y12.4%10Y9.5%+2.9%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ12.7%0.9%+11.8%
TTM12.7%1.0%+11.7%
YOY12.3%3.4%+8.9%
5Y12.4%1.1%+11.3%
10Y9.5%0.8%+8.7%

1.2. Operating Efficiency of Luyan Pharma Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Luyan is operating .

  • Measures how much profit Luyan makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 3.6% means the company generated ¥0.04  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Luyan Pharma Co Ltd:

  • The MRQ is 3.6%. The company is operating less efficient.
  • The TTM is 3.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.6%0.0%
TTM3.6%YOY3.4%+0.2%
TTM3.6%5Y3.5%+0.2%
5Y3.5%10Y2.8%+0.7%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%2.8%+0.8%
TTM3.6%1.1%+2.5%
YOY3.4%1.4%+2.0%
5Y3.5%1.1%+2.4%
10Y2.8%1.3%+1.5%
1.2.2. Operating Ratio

Measures how efficient Luyan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ¥1.88 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Luyan Pharma Co Ltd:

  • The MRQ is 1.884. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.884. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.884TTM1.8840.000
TTM1.884YOY1.885-0.002
TTM1.8845Y1.885-0.001
5Y1.88510Y1.692+0.193
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8841.673+0.211
TTM1.8841.653+0.231
YOY1.8851.541+0.344
5Y1.8851.516+0.369
10Y1.6921.342+0.350

1.3. Liquidity of Luyan Pharma Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Luyan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.17 means the company has ¥1.17 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Luyan Pharma Co Ltd:

  • The MRQ is 1.174. The company is just able to pay all its short-term debts.
  • The TTM is 1.174. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.174TTM1.1740.000
TTM1.174YOY1.186-0.012
TTM1.1745Y1.181-0.007
5Y1.18110Y0.970+0.211
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1741.206-0.032
TTM1.1741.178-0.004
YOY1.1861.236-0.050
5Y1.1811.439-0.258
10Y0.9701.340-0.370
1.3.2. Quick Ratio

Measures if Luyan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.70 means the company can pay off ¥0.70 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Luyan Pharma Co Ltd:

  • The MRQ is 0.703. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.703. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.703TTM0.7030.000
TTM0.703YOY0.722-0.018
TTM0.7035Y0.687+0.016
5Y0.68710Y0.692-0.005
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7030.449+0.254
TTM0.7030.495+0.208
YOY0.7220.507+0.215
5Y0.6870.558+0.129
10Y0.6920.680+0.012

1.4. Solvency of Luyan Pharma Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Luyan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Luyan to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.76 means that Luyan assets are financed with 76.3% credit (debt) and the remaining percentage (100% - 76.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Luyan Pharma Co Ltd:

  • The MRQ is 0.763. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.763. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.763TTM0.7630.000
TTM0.763YOY0.744+0.019
TTM0.7635Y0.740+0.023
5Y0.74010Y0.739+0.001
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7630.666+0.097
TTM0.7630.678+0.085
YOY0.7440.669+0.075
5Y0.7400.636+0.104
10Y0.7390.601+0.138
1.4.2. Debt to Equity Ratio

Measures if Luyan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 330.5% means that company has ¥3.31 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Luyan Pharma Co Ltd:

  • The MRQ is 3.305. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.305. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.305TTM3.3050.000
TTM3.305YOY2.983+0.322
TTM3.3055Y2.966+0.339
5Y2.96610Y3.070-0.104
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3051.780+1.525
TTM3.3051.727+1.578
YOY2.9831.910+1.073
5Y2.9661.983+0.983
10Y3.0701.582+1.488

2. Market Valuation of Luyan Pharma Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Luyan generates.

  • Above 15 is considered overpriced but always compare Luyan to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 9.38 means the investor is paying ¥9.38 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Luyan Pharma Co Ltd:

  • The EOD is 9.320. Based on the earnings, the company is underpriced. +1
  • The MRQ is 9.376. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.376. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.320MRQ9.376-0.056
MRQ9.376TTM9.3760.000
TTM9.376YOY9.920-0.544
TTM9.3765Y13.539-4.162
5Y13.53910Y33.465-19.926
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD9.3209.486-0.166
MRQ9.37610.789-1.413
TTM9.37611.594-2.218
YOY9.9205.513+4.407
5Y13.5397.416+6.123
10Y33.46514.965+18.500
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Luyan Pharma Co Ltd:

  • The EOD is -33.722. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -33.925. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -33.925. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.722MRQ-33.925+0.204
MRQ-33.925TTM-33.9250.000
TTM-33.925YOY-4.930-28.995
TTM-33.9255Y-143.452+109.527
5Y-143.45210Y-82.707-60.745
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-33.7222.180-35.902
MRQ-33.9252.232-36.157
TTM-33.9252.097-36.022
YOY-4.9300.506-5.436
5Y-143.4522.628-146.080
10Y-82.707-2.151-80.556
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Luyan is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 1.16 means the investor is paying ¥1.16 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Luyan Pharma Co Ltd:

  • The EOD is 1.153. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.160. Based on the equity, the company is underpriced. +1
  • The TTM is 1.160. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.153MRQ1.160-0.007
MRQ1.160TTM1.1600.000
TTM1.160YOY1.185-0.026
TTM1.1605Y1.590-0.430
5Y1.59010Y3.029-1.439
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD1.1531.218-0.065
MRQ1.1601.398-0.238
TTM1.1601.247-0.087
YOY1.1851.522-0.337
5Y1.5902.088-0.498
10Y3.0292.712+0.317
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Luyan Pharma Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5930.5930%0.396+50%0.630-6%0.603-2%
Book Value Per Share--7.1837.1830%6.589+9%5.816+23%4.168+72%
Current Ratio--1.1741.1740%1.186-1%1.181-1%0.970+21%
Debt To Asset Ratio--0.7630.7630%0.744+3%0.740+3%0.739+3%
Debt To Equity Ratio--3.3053.3050%2.983+11%2.966+11%3.070+8%
Dividend Per Share--0.8520.8520%0.644+32%0.577+48%0.401+112%
Eps--0.8880.8880%0.787+13%0.697+27%0.441+101%
Free Cash Flow Per Share---0.246-0.2460%-1.584+545%-0.844+244%-0.674+175%
Free Cash Flow To Equity Per Share--0.2290.2290%-0.360+257%0.148+55%0.162+42%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.800+25%
Intrinsic Value_10Y_max--22.298--------
Intrinsic Value_10Y_min--2.084--------
Intrinsic Value_1Y_max---0.060--------
Intrinsic Value_1Y_min---0.584--------
Intrinsic Value_3Y_max--1.569--------
Intrinsic Value_3Y_min---1.079--------
Intrinsic Value_5Y_max--5.306--------
Intrinsic Value_5Y_min---0.829--------
Market Cap3216920693.760-1%3236346543.3603236346543.3600%3034317707.520+7%3373205538.962-4%4894284529.171-34%
Net Profit Margin--0.0180.0180%0.017+2%0.017+4%0.013+32%
Operating Margin--0.0360.0360%0.034+6%0.035+5%0.028+31%
Operating Ratio--1.8841.8840%1.8850%1.8850%1.692+11%
Pb Ratio1.153-1%1.1601.1600%1.185-2%1.590-27%3.029-62%
Pe Ratio9.320-1%9.3769.3760%9.920-5%13.539-31%33.465-72%
Price Per Share8.280-1%8.3308.3300%7.810+7%8.682-4%12.597-34%
Price To Free Cash Flow Ratio-33.722+1%-33.925-33.9250%-4.930-85%-143.452+323%-82.707+144%
Price To Total Gains Ratio5.728-1%5.7635.7630%7.511-23%8.870-35%15.887-64%
Quick Ratio--0.7030.7030%0.722-3%0.687+2%0.692+2%
Return On Assets--0.0290.0290%0.031-4%0.031-6%0.025+19%
Return On Equity--0.1270.1270%0.123+3%0.124+2%0.095+34%
Total Gains Per Share--1.4451.4450%1.040+39%1.208+20%1.005+44%
Usd Book Value--385667703.108385667703.1080%353809910.958+9%312293950.219+23%223810689.999+72%
Usd Book Value Change Per Share--0.0820.0820%0.055+50%0.087-6%0.083-2%
Usd Book Value Per Share--0.9930.9930%0.911+9%0.804+23%0.576+72%
Usd Dividend Per Share--0.1180.1180%0.089+32%0.080+48%0.055+112%
Usd Eps--0.1230.1230%0.109+13%0.096+27%0.061+101%
Usd Free Cash Flow---13183819.775-13183819.7750%-85063689.390+545%-45314748.674+244%-32592509.026+147%
Usd Free Cash Flow Per Share---0.034-0.0340%-0.219+545%-0.117+244%-0.093+175%
Usd Free Cash Flow To Equity Per Share--0.0320.0320%-0.050+257%0.020+55%0.022+42%
Usd Market Cap444578439.878-1%447263092.292447263092.2920%419342707.179+7%466177005.485-4%676390121.931-34%
Usd Price Per Share1.144-1%1.1511.1510%1.079+7%1.200-4%1.741-34%
Usd Profit--47700489.96047700489.9600%42271318.681+13%37445722.805+27%23692281.332+101%
Usd Revenue--2689717676.5552689717676.5550%2424773902.378+11%2184912814.390+23%1558721906.182+73%
Usd Total Gains Per Share--0.2000.2000%0.144+39%0.167+20%0.139+44%
 EOD+3 -5MRQTTM+0 -0YOY+28 -75Y+24 -1110Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Luyan Pharma Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.320
Price to Book Ratio (EOD)Between0-11.153
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.036
Quick Ratio (MRQ)Greater than10.703
Current Ratio (MRQ)Greater than11.174
Debt to Asset Ratio (MRQ)Less than10.763
Debt to Equity Ratio (MRQ)Less than13.305
Return on Equity (MRQ)Greater than0.150.127
Return on Assets (MRQ)Greater than0.050.029
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Luyan Pharma Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.379
Ma 20Greater thanMa 508.153
Ma 50Greater thanMa 1007.831
Ma 100Greater thanMa 2008.398
OpenGreater thanClose8.330
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Minority Interest  84,19212,13796,330-30,55665,774-64,5151,259-7,078-5,819



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets11,783,796
Total Liabilities8,993,147
Total Stockholder Equity2,720,813
 As reported
Total Liabilities 8,993,147
Total Stockholder Equity+ 2,720,813
Total Assets = 11,783,796

Assets

Total Assets11,783,796
Total Current Assets9,748,241
Long-term Assets2,035,555
Total Current Assets
Cash And Cash Equivalents 594,190
Net Receivables 5,837,079
Inventory 2,548,589
Other Current Assets 668,174
Total Current Assets  (as reported)9,748,241
Total Current Assets  (calculated)9,648,033
+/- 100,208
Long-term Assets
Property Plant Equipment 1,425,217
Goodwill 289,451
Intangible Assets 176,934
Other Assets 109,746
Long-term Assets  (as reported)2,035,555
Long-term Assets  (calculated)2,001,349
+/- 34,207

Liabilities & Shareholders' Equity

Total Current Liabilities8,301,010
Long-term Liabilities692,137
Total Stockholder Equity2,720,813
Total Current Liabilities
Short Long Term Debt 4,455,270
Accounts payable 3,258,174
Other Current Liabilities 371,790
Total Current Liabilities  (as reported)8,301,010
Total Current Liabilities  (calculated)8,085,233
+/- 215,777
Long-term Liabilities
Long term Debt 471,764
Capital Lease Obligations Min Short Term Debt53,859
Other Liabilities 163,241
Deferred Long Term Liability 28,959
Long-term Liabilities  (as reported)692,137
Long-term Liabilities  (calculated)717,824
+/- 25,687
Total Stockholder Equity
Common Stock388,517
Retained Earnings 1,675,876
Other Stockholders Equity 2,825
Total Stockholder Equity (as reported)2,720,813
Total Stockholder Equity (calculated)2,067,217
+/- 653,596
Other
Capital Stock388,517
Common Stock Shares Outstanding 388,517
Net Debt 4,332,844
Net Invested Capital 7,647,847
Net Tangible Assets 2,254,428
Net Working Capital 1,447,231
Property Plant and Equipment Gross 1,425,217



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
1,328,077
2,222,499
2,823,929
3,314,008
3,430,711
3,511,458
5,132,423
6,070,517
7,537,992
8,434,883
9,992,695
11,783,796
11,783,7969,992,6958,434,8837,537,9926,070,5175,132,4233,511,4583,430,7113,314,0082,823,9292,222,4991,328,077
   > Total Current Assets 
0
0
0
0
2,988,689
2,983,689
4,279,622
4,982,328
6,290,726
7,208,504
8,322,289
9,748,241
9,748,2418,322,2897,208,5046,290,7264,982,3284,279,6222,983,6892,988,6890000
       Cash And Cash Equivalents 
170,688
282,702
355,341
579,707
470,254
424,704
541,809
516,717
428,935
595,366
415,434
594,190
594,190415,434595,366428,935516,717541,809424,704470,254579,707355,341282,702170,688
       Net Receivables 
803,791
1,243,449
1,538,195
1,679,073
1,840,564
1,666,783
2,322,431
2,851,590
3,687,886
3,920,271
5,062,496
5,837,079
5,837,0795,062,4963,920,2713,687,8862,851,5902,322,4311,666,7831,840,5641,679,0731,538,1951,243,449803,791
       Other Current Assets 
36,593
86,049
88,051
88,802
107,560
144,437
347,643
323,227
414,963
378,694
414,116
668,174
668,174414,116378,694414,963323,227347,643144,437107,56088,80288,05186,04936,593
   > Long-term Assets 
0
0
0
0
0
527,770
852,801
1,088,188
1,247,266
1,342,339
1,670,406
2,035,555
2,035,5551,670,4061,342,3391,247,2661,088,188852,801527,77000000
       Property Plant Equipment 
65,708
147,344
280,070
317,770
317,631
401,725
555,120
623,376
744,655
825,412
1,036,656
1,425,217
1,425,2171,036,656825,412744,655623,376555,120401,725317,631317,770280,070147,34465,708
       Goodwill 
7,171
11,705
35,419
35,437
33,969
28,136
119,234
289,164
301,383
283,883
289,451
289,451
289,451289,451283,883301,383289,164119,23428,13633,96935,43735,41911,7057,171
       Long Term Investments 
0
0
0
0
0
0
500
300
0
0
0
0
0000300500000000
       Intangible Assets 
22,622
27,420
68,570
97,807
61,677
60,098
82,179
108,251
117,280
113,234
167,810
176,934
176,934167,810113,234117,280108,25182,17960,09861,67797,80768,57027,42022,622
       Long-term Assets Other 
0
0
0
0
0
47
35,846
2,244
13,330
45,222
64,062
1,395
1,39564,06245,22213,3302,24435,8464700000
> Total Liabilities 
973,165
1,776,177
2,267,704
2,664,703
2,684,710
2,133,277
3,566,063
4,416,939
5,649,973
6,028,635
7,432,566
8,993,147
8,993,1477,432,5666,028,6355,649,9734,416,9393,566,0632,133,2772,684,7102,664,7032,267,7041,776,177973,165
   > Total Current Liabilities 
972,346
1,775,496
2,250,184
2,646,602
2,663,972
2,109,155
3,394,718
4,214,740
5,507,022
5,910,344
7,015,230
8,301,010
8,301,0107,015,2305,910,3445,507,0224,214,7403,394,7182,109,1552,663,9722,646,6022,250,1841,775,496972,346
       Short-term Debt 
0
0
0
0
0
901,363
1,720,318
2,122,354
0
0
0
0
00002,122,3541,720,318901,36300000
       Short Long Term Debt 
0
0
0
0
0
901,363
1,720,318
2,122,354
3,096,237
3,344,974
4,130,445
4,455,270
4,455,2704,130,4453,344,9743,096,2372,122,3541,720,318901,36300000
       Accounts payable 
668,988
1,116,634
1,261,199
1,463,220
1,458,065
1,146,573
1,264,888
1,681,683
1,915,093
2,006,354
2,410,500
3,258,174
3,258,1742,410,5002,006,3541,915,0931,681,6831,264,8881,146,5731,458,0651,463,2201,261,1991,116,634668,988
       Other Current Liabilities 
31,157
112,602
79,255
69,199
38,678
37,081
177,667
189,742
312,190
416,970
273,677
371,790
371,790273,677416,970312,190189,742177,66737,08138,67869,19979,255112,60231,157
   > Long-term Liabilities 
0
0
0
0
0
24,121
171,345
202,199
142,951
213,335
417,336
692,137
692,137417,336213,335142,951202,199171,34524,12100000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-901,363
-1,720,318
-2,122,354
0
71,650
40,372
53,859
53,85940,37271,6500-2,122,354-1,720,318-901,36300000
       Long-term Liabilities Other 
0
0
0
0
0
15,654
48,800
119,400
116,700
0
0
0
000116,700119,40048,80015,65400000
       Deferred Long Term Liability 
0
0
0
0
16,685
22,183
35,302
41,178
36,049
33,729
32,816
28,959
28,95932,81633,72936,04941,17835,30222,18316,6850000
> Total Stockholder Equity
354,035
444,570
552,781
642,270
737,565
1,370,190
1,473,719
1,569,385
1,791,689
2,340,475
2,491,664
2,720,813
2,720,8132,491,6642,340,4751,791,6891,569,3851,473,7191,370,190737,565642,270552,781444,570354,035
   Common Stock
96,119
96,119
96,119
96,119
96,119
128,169
128,169
192,253
326,830
388,517
388,517
388,517
388,517388,517388,517326,830192,253128,169128,16996,11996,11996,11996,11996,119
   Retained Earnings 
116,339
206,873
315,270
405,446
499,702
589,592
694,537
785,143
1,002,581
1,240,300
1,447,275
1,675,876
1,675,8761,447,2751,240,3001,002,581785,143694,537589,592499,702405,446315,270206,873116,339
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
908
2,159
743
1,863
2,486
495
-495
2,825
2,825-4954952,4861,8637432,1599080000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue19,913,899
Cost of Revenue-18,395,645
Gross Profit1,518,2541,518,254
 
Operating Income (+$)
Gross Profit1,518,254
Operating Expense-19,181,011
Operating Income732,888-17,662,757
 
Operating Expense (+$)
Research Development4,125
Selling General Administrative498,608
Selling And Marketing Expenses-
Operating Expense19,181,011502,732
 
Net Interest Income (+$)
Interest Income4,342
Interest Expense-220,719
Other Finance Cost-5,056
Net Interest Income-221,434
 
Pretax Income (+$)
Operating Income732,888
Net Interest Income-221,434
Other Non-Operating Income Expenses-
Income Before Tax (EBT)455,965732,888
EBIT - interestExpense = -220,719
356,272
576,991
Interest Expense220,719
Earnings Before Interest and Taxes (EBIT)-676,685
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax455,965
Tax Provision-97,890
Net Income From Continuing Ops358,075358,075
Net Income356,272
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-221,434
 

Technical Analysis of Luyan
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Luyan. The general trend of Luyan is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Luyan's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Luyan Pharma Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8.3234431554524 < 8.45 < 8.4976801346801.

The bearish price targets are: 7.79 > 7.67 > 7.45.

Tweet this
Luyan Pharma Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Luyan Pharma Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Luyan Pharma Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Luyan Pharma Co Ltd. The current macd is 0.07018277.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Luyan price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Luyan. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Luyan price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Luyan Pharma Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLuyan Pharma Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Luyan Pharma Co Ltd. The current adx is 9.88661941.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Luyan shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Luyan Pharma Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Luyan Pharma Co Ltd. The current sar is 7.915.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Luyan Pharma Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Luyan Pharma Co Ltd. The current rsi is 55.38. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Luyan Pharma Co Ltd Daily Relative Strength Index (RSI) ChartLuyan Pharma Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Luyan Pharma Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Luyan price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Luyan Pharma Co Ltd Daily Stochastic Oscillator ChartLuyan Pharma Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Luyan Pharma Co Ltd. The current cci is 113.25.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Luyan Pharma Co Ltd Daily Commodity Channel Index (CCI) ChartLuyan Pharma Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Luyan Pharma Co Ltd. The current cmo is 12.37.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Luyan Pharma Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLuyan Pharma Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Luyan Pharma Co Ltd. The current willr is -43.02325581.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Luyan is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Luyan Pharma Co Ltd Daily Williams %R ChartLuyan Pharma Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Luyan Pharma Co Ltd.

Luyan Pharma Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Luyan Pharma Co Ltd. The current atr is 0.24312257.

Luyan Pharma Co Ltd Daily Average True Range (ATR) ChartLuyan Pharma Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Luyan Pharma Co Ltd. The current obv is 202,165,525.

Luyan Pharma Co Ltd Daily On-Balance Volume (OBV) ChartLuyan Pharma Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Luyan Pharma Co Ltd. The current mfi is 77.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Luyan Pharma Co Ltd Daily Money Flow Index (MFI) ChartLuyan Pharma Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Luyan Pharma Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Luyan Pharma Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Luyan Pharma Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.379
Ma 20Greater thanMa 508.153
Ma 50Greater thanMa 1007.831
Ma 100Greater thanMa 2008.398
OpenGreater thanClose8.330
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Luyan with someone you think should read this too:
  • Are you bullish or bearish on Luyan? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Luyan? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Luyan Pharma Co Ltd

I send you an email if I find something interesting about Luyan Pharma Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Luyan Pharma Co Ltd.

Receive notifications about Luyan Pharma Co Ltd in your mailbox!